{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:08:10Z","timestamp":1791220090687,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1124\/mol.108.049353","type":"journal-article","created":{"date-parts":[[2008,7,16]],"date-time":"2008-07-16T03:54:34Z","timestamp":1216180474000},"page":"1119-1131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["New Insights into the Function of M4 Muscarinic Acetylcholine Receptors Gained Using a Novel Allosteric Modulator and a DREADD (Designer Receptor Exclusively Activated by a Designer Drug)"],"prefix":"10.1016","volume":"74","author":[{"given":"Vindhya","family":"Nawaratne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Leach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur","family":"Suratman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Loiacono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian C.","family":"Felder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaine N.","family":"Armbruster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan L.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Sexton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Christopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.108.049353_REF1","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1073\/pnas.0700293104","article-title":"Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand","volume":"104","author":"Armbruster","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/mol.108.049353_REF2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1476-5381.1983.tb09388.x","article-title":"The effect of McN-A-343 on muscarinic receptors in the cerebral cortex and heart","volume":"78","author":"Birdsall","year":"1983","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.108.049353_REF3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev.biophys.29.1.577","article-title":"Unnatural ligands for engineered proteins: new tools for chemical genetics","volume":"29","author":"Bishop","year":"2000","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"10.1124\/mol.108.049353_REF4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Analyt Biochem"},{"key":"10.1124\/mol.108.049353_REF5","doi-asserted-by":"crossref","first-page":"10978","DOI":"10.1073\/pnas.0800567105","article-title":"Allosteric modulation of the muscarinic M4 receptor as a novel approach to treating schizophrenia","volume":"105","author":"Chan","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/mol.108.049353_REF6","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.108.049353_REF7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0165-6147(98)01240-1","article-title":"Assessing the distribution of parameters in models of ligand-receptor interaction: to log or not to log","volume":"19","author":"Christopoulos","year":"1998","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.108.049353_REF8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nrd746","article-title":"Allosteric binding sites on cell-surface receptors: novel targets for drug discovery","volume":"1","author":"Christopoulos","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/mol.108.049353_REF9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/pr.54.2.323","article-title":"G protein-coupled receptor allosterism and complexing","volume":"54","author":"Christopoulos","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1124\/mol.108.049353_REF10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00213-004-2017-1","article-title":"The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine\u2019s actions?","volume":"178","author":"Davies","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1124\/mol.108.049353_REF11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0026-895X(25)13145-3","article-title":"Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods","volume":"33","author":"Ehlert","year":"1988","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.108.049353_REF12","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1124\/jpet.108.136960","article-title":"Two-state models and the analysis of the allosteric effect of gallamine at the M2 muscarinic receptor","volume":"325","author":"Ehlert","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl S1","key":"10.1124\/mol.108.049353_REF13","first-page":"S115","article-title":"Pharmacological and molecular characterization of a positive allosteric modulator selective for the muscarinic M4 receptor being developed for treatment of psychosis (Abstract)","volume":"29","author":"Felder","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/mol.108.049353_REF14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/157015907781695946","article-title":"Allosteric modulation of muscarinic acetylcholine receptors","volume":"5","author":"Gregory","year":"2007","journal-title":"Curr Neuropharmacol"},{"key":"10.1124\/mol.108.049353_REF15","series-title":"Pharmacologic Analysis of Drug-Receptor Interaction","author":"Kenakin","year":"1997"},{"key":"10.1124\/mol.108.049353_REF16","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.tips.2007.06.004","article-title":"Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology","volume":"28","author":"Leach","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.108.049353_REF17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/mol.107.037630","article-title":"Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors","volume":"72","author":"May","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.108.049353_REF18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.47.120505.105159","article-title":"Allosteric Modulation of G Protein-Coupled Receptors","volume":"47","author":"May","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/mol.108.049353_REF19","series-title":"Fitting Models to Biological Data Using Linear and Nonlinear Regression. A Practical Guide to Curve-Fitting","author":"Motulsky","year":"2004"},{"key":"10.1124\/mol.108.049353_REF20","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1124\/mol.105.016162","article-title":"Allosteric modulation of the cannabinoid CB1 receptor","volume":"68","author":"Price","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.108.049353_REF21","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0165-6147(00)01743-0","article-title":"Engineering receptors activated solely by synthetic ligands (RASSLs)","volume":"22","author":"Scearce-Levie","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.108.049353_REF22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nchembio.2007.55","article-title":"An allosteric potentiator of M4 mAChR modulates hippocampal synaptic transmission","volume":"4","author":"Shirey","year":"2008","journal-title":"Nat Chem Biol"},{"key":"10.1124\/mol.108.049353_REF23","doi-asserted-by":"crossref","first-page":"13674","DOI":"10.1073\/pnas.1835612100","article-title":"desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl-d-aspartate receptor activity","volume":"100","author":"Sur","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/mol.108.049353_REF24","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0026-895X(25)09800-1","article-title":"Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors","volume":"46","author":"Waelbroeck","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.108.049353_REF25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/10606820308262","article-title":"M1-M5 muscarinic receptor knockout mice as novel tools to study the physiological roles of the muscarinic cholinergic system","volume":"9","author":"Wess","year":"2003","journal-title":"Recept Channels"},{"key":"10.1124\/mol.108.049353_REF26","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrd2379","article-title":"Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development","volume":"6","author":"Wess","year":"2007","journal-title":"Nat Rev Drug Discov"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24145749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24145749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.108.049353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T10:24:00Z","timestamp":1740047040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24145749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0026895X24145749"],"URL":"https:\/\/doi.org\/10.1124\/mol.108.049353","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Insights into the Function of M4 Muscarinic Acetylcholine Receptors Gained Using a Novel Allosteric Modulator and a DREADD (Designer Receptor Exclusively Activated by a Designer Drug)","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.108.049353","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}